Browsing by Author Bellet Ezquerra, Meritxell

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 5 to 9 of 9 < previous 
Issue DateTitleAuthor(s)
1-May-2019Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medicationBellet Ezquerra, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miguel Àngel; Peña, Lorena de la
27-Sep-2022Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER TrialAlbanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet Ezquerra, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertran, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio
3-Nov-2023Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast CancerJhaveri, Komal L.; Bellet Ezquerra, Meritxell; Turner, Nicholas C.; Loi, Sherene; Bardia, Aditya; Boni, Valentina; Sohn, Joohyuk; Neilan, Tomas G.; Villanueva Vázquez, Rafael; Kabos, Peter; García Estévez, Laura; López Miranda, Elena; Pérez Fidalgo, J. Alejandro; Pérez García, Jose M.; Yu, Jiajie; Fredrickson, Jill; Moore, Heather M.; Chang, Ching-Wei; Bond, John W.; Eng-Wong, Jennifer; Gates, Mary R.; Lim, Elgene
28-Sep-2022Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trialSalvador Bofill, Javier; Moreno Anton, Fernando; Rodríguez Sánchez, César A.; Galve Calvo, Elena; Hernando Melia, Cristina; Ciruelos, Eva; Vidal Losada, Maria Jesús; Jiménez Rodriguez, Begoña; De La Cruz Merino, Luis; Martínez Jañez, Noelia; Villanueva Vazquez, Rafael; De Toro Salas, Ruben; Anton Torres, Antonio; Alvarez Lopez, Isabel Manuela; Gavila Gregori, Joaquin; Quiroga Garcia, Vanesa; Vicente Rubio, Elena; De La Haba Rodriguez, Juan; Gonzalez Santiago, Santiago; Diaz Fernandez, Nieves; Barnadas Molins, Agusti; Cantos Sanchez De Ibargüen, Blanca; Delgado Mingorance, Juan Ignacio; Bellet Ezquerra, Meritxell; De Casa, Sonia; Gimeno, Asuncion; Martin, Miguel
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix